Welcome to the e-CCO Library!

OP29: Peri-natal exposure to parental Crohn's disease is associated with impaired gut barrier, microbiome composition differences and increased risk of Crohn's disease
Year: 2023
Source: ECCO’23 Copenhagen
Authors: LeeDr., S.H.(1)*;Qiu, L.(1);A. Olivera, P.(1);Leibovitzh, H.(1);Xue, M.(1);Neustaeter, A.(1);Mbareche, H.(1);Xu, W.(2);Espin-Garcia, O.(2); L. Aumais, G.(3);Q. Huynh, H.(4);Panaccione, R.(5);Steinhart, A.H.(1);Cino, M.(6);Mack, D.(7);K. Marshall, J.(8);Ropeleski, M.(9);Bitton, A.(10);Jacobson, K.(11);McGraft, J.(12);Yerushalmi, B.(13);Abreu, M.(14);N. Bernstein, C.(15);Radford-Smith, G.(16);Lees, C.(17);Turner, D.(18);L. Madsen, K.(4);S. Guttman, D.(19);S. Silverberg, M.(1);Turpin, W.(1);Croitoru, K.(1);
Created: Friday, 14 July 2023, 10:43 AM
OP29: Peripheral blood DNA methylation biomarkers accurately predict clinical- and endoscopic response to vedolizumab in a real-life cohort of Crohn’s Disease patients
Year: 2022
Source: ECCO'22
Authors: Joustra, V.(1);Hageman, I.(1,2);Li Yim, A.(2,3);Levin, E.(4,5);Satsangi, J.(6);Adams, A.(6);De Jonge, W.(2);Henneman, P.(3);D'Haens, G.(1); on behalf of the EPIC consortium
Created: Friday, 11 February 2022, 3:52 PM
OP29: ST2+/IL-33 responsive cells promote tumorigenesis in colitis-associated colorectal cancer
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

L. R. Lopetuso*1, C. De Salvo2, L. Di Martino2, W. Goodman2, F. Scaldaferri1, A. Armuzzi1, A. Gasbarrini1, T. T. Pizarro2

Created: Friday, 22 February 2019, 9:41 AM
OP30 The interplay of microbiome dysbiosis and immune system deregulation in patients with Crohn’s disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

N.S. Seyed Tabib1, C. Caenepeel1, K. Machiels1, S. Verstockt1, B. Verstockt1,2, N. Ardeshir Davani1, J. Sabino1,2, M. Ferrante1,2, S. Vermeire1,2

Created: Thursday, 30 January 2020, 10:12 AM
OP30: Human umbilical cord mesenchymal stem cells derived exosomes alleviate Ulcerative Colitis by inhibiting macrophage ferroptosis via miR-23b-3p/Nrf2 pathway
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Liu, L.(1)*;Zhao, J.(1);Ye, Y.(1);Feng, Z.(1);Wang, X.(1);Cao, X.(1);
Created: Friday, 14 July 2023, 10:43 AM
OP30: Lyophilised orally administered faecal microbiota transplantation for Active Ulcerative Colitis (LOTUS study)
Year: 2021
Source: ECCO'21 Virtual
Authors: Haifer, C.(1);Saikal, A.(2);Paramsothy, S.(1);Borody, T.J.(3);Ghaly, S.(2);Kaakoush, N.O.(4);Leong, R.(1)
Created: Wednesday, 2 June 2021, 4:12 PM
OP30: Serum proteomic profiling predicts and diagnoses pouchitis in ulcerative colitis patients undergoing ileal pouch-anal anastomosis
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

K. Machiels*1, M. Ferrante1,2, N. Davani1, A. Wolthuis3, A. D’Hoore3, S. Vermeire1,2

Created: Friday, 22 February 2019, 9:41 AM
OP30: Upadacitinib modulates inflammatory pathways in gut tissue in patients with Ulcerative Colitis: Transcriptomic profiling from the Phase 2b study, U-ACHIEVE
Year: 2022
Source: ECCO'22
Authors: Verstockt, B.(1);Blink Polakow, S.(2);Mahi, N.(2);Lee, J.(2);Wang, J.(3);Guay, H.(4);Salas, A.(5);Panés, J.(5);Ungaro, R.C.(6);Vermeire, S.(1);
Created: Friday, 11 February 2022, 3:52 PM
OP31 Meta–omics reveals microbiome-driven proteolysis as a contributing factor to the severity of ulcerative colitis disease activity
Year: 2020
Source:

ECCO'20 Vienna

Authors:

R. Mills1, P. Dulai2, Y. Vázquez-Baeza3, Q. Zhu3, G. Humphrey3, L. DeRight Goldasich3, R. Quinn4, A. Gewirtz5, B. Chassaing5, H. Chu6, W. Sandborn2, P. Dorrestein1, R. Knight3, D. Gonzalez1

Created: Thursday, 30 January 2020, 10:12 AM
OP31: Dietary and Multi-Omic characterization of new onset treatment naive Crohn Disease identifies factors that may contribute to disease pathogenesis
Year: 2022
Source: ECCO'22
Authors: Haberman Ziv, Y.(1);Braun, T.(1);Amir, A.(1);Levhar , N.(1);Malik, A.(1);Neuman, S.(1);Picard, O.(1);Yavzuri, M.(1);Efroni, G.(1);Hadar, R.(1);Ben-Horin, S.(1);
Created: Friday, 11 February 2022, 3:52 PM
OP31: High fat diet exacerbates colitis through microbial metabolite deoxycholic acids induced-ferroptosis
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Wang, C.(1)*;Gu, Y.(1);Cao, H.(1);
Created: Friday, 14 July 2023, 10:43 AM
OP31: RESTORE: Interim analysis of a Phase 2 study of QBECO SSI for the induction and maintenance of clinical and endoscopic remission in subjects with Moderate to Severe Crohn’s Disease
Year: 2021
Source: ECCO'21 Virtual
Authors: Bressler, B.(1);Marshall, J.K.(2);Atkinson, K.(3);Sutcliffe, S.(4);Pankovich, J.(4);Jones, M.(4);Kalyan, S.(4);Gunn, H.(4)
Created: Wednesday, 2 June 2021, 4:12 PM
OP31: TP53 mutation in human colonic organoids acquires resistance to in vitro long-term inflammation
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

K. Tsuchiya*1, S. Watanabe1, T. Shirasaki1, R. Nishimura1, N. Katsukura1, S. Hibiya1, R. Okamoto1, T. Nakamura1, M. Watanabe1

Created: Friday, 22 February 2019, 9:41 AM
OP32 Mincle signalling promotes intestinal mucosal inflammation through induction of macrophage pyroptosis and neutrophil chemotaxis in Crohn’s disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

W. GONG1, K. Guo2, J. Ren3

Created: Thursday, 30 January 2020, 10:12 AM
OP32: A novel mechanism of colonic epithelial-T-cell cross-talk is dysregulated in IBD
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

R. J. Dart*1,2,3, P. Vantourout1,2, P. M. Irving3, A. Hayday1,2

Created: Friday, 22 February 2019, 9:41 AM
OP32: Pyroptosis Inhibition Prevents the Cytotoxicity Induced by IL-17 Without Impairing Its Beneficial Effects
Year: 2022
Source: ECCO'22
Authors: Hong, S.N.(1);Joo Hye , S.(1);Dong Kyung , C.(1);Young-Ho , K.(1);ji eun , K.(1);Ye Ji, S.(1);
Created: Friday, 11 February 2022, 3:52 PM
OP32: Stool microbiome communities predict remission in treatment-naïve Pediatric Crohn’s Disease patients
Year: 2021
Source: ECCO'21 Virtual
Authors: Verburgt, C.(1,2);Dunn, K.(3);Bielawski, J.(3,4);Otley, A.(5);Heyman, M.(6);Sunseri, W.(7);Shouval, D.(8);Levine, A.(9);de Meij, T.(1);Hyams, J.(10);Denson, L.(11);Kugathasan, S.(12);Benninga, M.(1);de Jonge, W.(2,13);Van Limbergen, J.(1,2,5)
Created: Wednesday, 2 June 2021, 4:12 PM
OP32: The gut virome-colonizing Orthohepadnavirus genus is associated with ulcerative colitis pathogenesis and induces intestinal inflammation in vivo
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Facoetti, A.(1)*;Massimino, L.(2);Palmieri, O.(3);Fuggetta , D.(1);Spanò , S.(2);D'Alessio , S.(4);Furfaro, F.(5);D'Amico, F.(5);ZIlli, A.(5);Fiorino, G.(5);Noviello, D.(6);Latiano, A.(3);Bossa, F.(3);Pirola, A.(7);Mologni, L.(8);Piazza, R.(8);Abbati, D.(9);Perri, F.(3);Bonini , C.(9);Peyrin-Biroulet, L.(10);Malesci, A.(5);Danese, S.(5);Ungaro, F.(2);
Created: Friday, 14 July 2023, 10:43 AM
OP33 Multi-omics analysis reveals specific bio-geographical and functional characteristics in inflammatory bowel disease intestinal mucosa
Year: 2020
Source:

ECCO'20 Vienna

Authors:

N. Maimon1,2, S. Gerassy-Vainberg1,2, H. Bar-Yosef1, A. Alpert2, E. Starosvetsky2, M. Abu-Arisha1, T. Shvedov1, S. Shen-Orr2, Y. Chowers1, Yehuda Chowers lab Shai Shen-Orr lab Israel

Created: Thursday, 30 January 2020, 10:12 AM
OP33: BUB1: a new player in the development of Crohn’s disease (CD)-associated fibrosis
Year: 2019
Source: ECCO '19 Copenhagen
Authors:

V. Garlatti*1, F. Ungaro1, S. Spanò1, S. D’Alessio1,2, S. Danese1,2

Created: Thursday, 28 February 2019, 8:13 AM
Files: 1